Prochlorperazine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
Condition:   Breast Carcinoma Interventions:   Drug: Dexamethasone;   Other: Laboratory Biomarker Analysis;   Drug: Netupitant/Palonosetron Hydrochloride;   Drug: Olanzapine;   Other: Placebo;   Drug: Prochlorperazine;   Other: Quality-of-Life Assessment Sponsors:   Gary Morrow;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2017 Category: Research Source Type: clinical trials